3 Largecap FII and DII Both Buying Stocks to Watch for Future Multibagger Potential: Laurus Labs, SBI Funds Management and Aditya Birla Capital

FII and DII both buying stocks to watch for multibagger potential start with a simple filter: size, a clean financial record and earnings that keep growing. Laurus Labs, SBI Funds Management and Aditya Birla Capital meet that test, with market caps from Rs 1.05 lakh crore to Rs 1.09 lakh crore and Laurus Labs offering the strongest latest-quarter profit growth at 124.73%. Both foreign and domestic institutions increased their holdings in each of these companies between June 2025 and June 2026.

This list covers large companies where both FII and DII holding rose by more than 1 percentage point between June 2025 and June 2026, with complete, verifiable financials, ranked by market capitalisation. Each company has a market cap above Rs 1 lakh crore. Investors screening FII and DII both buying stocks usually begin with size and balance sheet strength, and this list follows the same logic. All figures are as of 16 October 2026 and are drawn from NSE and BSE data and company filings.

Click Here – Get Free Investment Predictions

What Are FII and DII Both Buying Stocks and Why Do They Attract Multibagger Interest?

FII and DII both buying stocks are shares where both global funds and Indian institutions added to their stakes over the past year. When two very different groups of investors both buy, it is a strong sign of confidence in the business.

Foreign funds look at India against other markets, while domestic funds judge each company on local fundamentals. Companies that win money from both groups while growing profit are the ones investors compare in FII and DII both buying stocks.

FII and DII Both Buying Stocks at a Glance: Price, Market Cap, PE, ROE and Price to Book

Prices are closing prices as of 16 October 2026. Aditya Birla Capital has the lowest PE of the group at 25.39, while SBI Funds Management posts the highest return on equity at 51.44%.

Stock	CMP (Rs)	Market Cap (Rs Cr)	PE	Industry PE	ROE	Price to Book	52-Week Range (Rs)
Laurus Labs	2,060.10	1,09,143	100.10	36.42	16.77%	20.59	864.70 to 2,085.90
SBI Funds Management	507.65	1,05,732	34.47	17.97	51.44%	17.73	494.00 to 624.95
Aditya Birla Capital	379.40	1,04,535	25.39	17.68	10.96%	2.72	287.70 to 430.70

Laurus Labs: Revenue Up 22.01% in FY26

Laurus Labs makes active pharmaceutical ingredients and formulations and offers contract development and manufacturing services. It reported FY26 revenue of Rs 6,867.85 crore, up 22.01% year on year, and net profit of Rs 889.85 crore, up 151.08%. Revenue has compounded at 8.53% a year since FY22. Operating margin was 26.90% in FY26. The debt-to-equity ratio is 0.48.

In the June 2026 quarter, revenue rose 28.83% to Rs 2,035.49 crore and net profit grew 124.73% to Rs 361.99 crore. The share price has gained 221.40% over five years and 137.53% over the past year. Domestic institutions raised their holding from 11.94% in June 2025 to 13.74% in June 2026. The stock trades at a PE of 100.10 against an industry PE of 36.42, with a return on equity of 16.77%.

SBI Funds Management: 29.75% Profit CAGR Since FY22

SBI Funds Management is the asset management arm of the State Bank of India group and runs one of the largest mutual fund businesses in the country. It reported FY26 revenue of Rs 4,976.11 crore, up 17.47% year on year, and net profit of Rs 3,067.38 crore, up 20.76%. Net profit has compounded at 29.75% a year since FY22, while revenue has grown 25.59% a year. Operating margin was 81.61% in FY26. The debt-to-equity ratio is 0.00, which keeps interest costs low.

The stock trades at a PE of 34.47 against an industry PE of 17.97, with a return on equity of 51.44%. In the June 2026 quarter, revenue rose 4.64% to Rs 1,389.89 crore and net profit grew 3.70% to Rs 880.26 crore. Domestic institutions raised their holding from 0.00% in March 2026 to 2.97% in July 2026.

Aditya Birla Capital: 23.52% Profit CAGR Since FY22

Aditya Birla Capital is the financial services arm of the Aditya Birla Group, with lending, asset management, insurance and wealth businesses. It reported FY26 total income of Rs 45,617.39 crore, up 12.02% year on year, and net profit of Rs 3,863.80 crore, up 14.25%. Net profit has compounded at 23.52% a year since FY22, while total income has grown 19.67% a year.

In the June 2026 quarter, total income rose 27.87% to Rs 12,187.05 crore and net profit grew 43.25% to Rs 1,223.85 crore. The share price has gained 251.61% over five years and 25.70% over the past year. Domestic institutions raised their holding from 12.06% in June 2025 to 13.48% in June 2026. The stock trades at a PE of 25.39 against an industry PE of 17.68.

FII and DII Both Buying Stocks: Financial Comparison on Growth and Margins

The table compares scale and growth across these FII and DII both buying stocks. Latest quarter means the most recent reported quarter for each company, and only metrics that are positive for every company are shown.

Stock	Revenue (Rs Cr)	Net Profit (Rs Cr)	Revenue Growth (YoY)	4-Year Revenue CAGR	4-Year Net Profit CAGR
Laurus Labs	6,867.85	889.85	22.01%	8.53%	1.68%
SBI Funds Management	4,976.11	3,067.38	17.47%	25.59%	29.75%
Aditya Birla Capital	45,617.39	3,863.80	12.02%	19.67%	23.52%

Check the Univest Screener for live data on these FII and DII both buying stocks

Institutional Holding in Laurus Labs, SBI Funds Management and Aditya Birla Capital

Institutional holding shows who is backing these FII and DII both buying stocks alongside the promoter. The table uses the latest reported quarter for each. Laurus Labs has the deepest institutional backing, with FII and DII together holding 41.74% as of June 2026. Domestic institutions increased their holding over the past year in Laurus Labs (from 11.94% to 13.74%), SBI Funds Management (from 0.00% to 2.97%) and Aditya Birla Capital (from 12.06% to 13.48%).

Stock	Promoter	FII	DII	Public	Quarter
Laurus Labs	27.47%	28.00%	13.74%	30.78%	June 2026
SBI Funds Management	88.19%	1.43%	2.97%	7.41%	July 2026
Aditya Birla Capital	68.81%	8.60%	13.48%	9.12%	June 2026

Risks to Weigh in FII and DII Both Buying Stocks

Being careful with FII and DII both buying stocks means looking at what can slow the story as well as what can speed it up. Four points matter most:

• Holding data is reported once every quarter.
• Institutional flows can change with market conditions.
• Valuation: Laurus Labs trades at a PE of 100.10 against an industry PE of 36.42, so earnings need to keep growing to support the price.
• Concentration: Holding all 3 names puts the allocation in one sector, so size each position to match your risk appetite.

How to Choose Between FII and DII Both Buying Stocks

Picking from FII and DII both buying stocks comes down to four checks, applied in order.

1. Check balance sheet strength first, and prefer a debt-to-equity ratio below 1 for non-financial companies.
2. Compare each PE with the industry PE (17.68 to 36.42) and ask whether the growth rate justifies any gap.
3. Track the quarterly shareholding pattern, profit growth and the return on equity in every update.
4. Stagger entries across quarters and review institutional holding every reporting season.

Download the Univest iOS App or Univest Android App to track Laurus Labs, SBI Funds Management and Aditya Birla Capital live prices.

Conclusion

Among FII and DII both buying stocks, Laurus Labs stands out for the strongest latest-quarter profit growth at 124.73%, SBI Funds Management for the highest return on equity at 51.44% and Aditya Birla Capital for the biggest five-year price gain at 251.61%. Which one suits a portfolio depends on how much valuation risk it can carry, so staggering entries and reviewing each quarterly result is a sound habit. Investors comparing FII and DII both buying stocks should rank them on growth, financial strength and the price paid, and anyone who wants personalised guidance can consult a SEBI-registered advisor before acting.

Frequently Asked Questions on FII and DII Both Buying Stocks to Watch

Which are the best FII and DII both buying stocks to watch for multibagger potential?

Ans. Laurus Labs, SBI Funds Management and Aditya Birla Capital are the 3 names this list highlights, with market caps of Rs 1,09,143 crore, Rs 1,05,732 crore and Rs 1,04,535 crore respectively. Laurus Labs is notable for the strongest latest-quarter profit growth at 124.73%. SBI Funds Management stands out for the highest return on equity at 51.44%. Aditya Birla Capital offers the biggest five-year price gain at 251.61%. These are watchlist names for FII and DII both buying stocks, not recommendations, so match each one to your own risk profile and time horizon.

Is SBI Funds Management a good stock for long-term investors?

Ans. SBI Funds Management has a return on equity of 51.44%, a PE of 34.47 against an industry PE of 17.97 and a market cap of Rs 1,05,732 crore. Net profit has compounded at 29.75% a year since FY22, and FY26 revenue rose 17.47% while June 2026 quarter net profit grew 3.70%. Long-term returns in FII and DII both buying stocks depend on earnings growth and the price paid at entry, so staggering purchases and consulting a SEBI-registered advisor is sensible.

Can Aditya Birla Capital become a multibagger from here?

Ans. Aditya Birla Capital has already gained 251.61% in five years, so another multi-fold move would need sustained earnings growth. A multibagger outcome in FII and DII both buying stocks requires earnings to keep growing faster than the market for several years. Net profit has compounded at 23.52% a year since FY22, and FY26 revenue rose 12.02%. At a PE of 25.39 against an industry PE of 17.68, valuation should be checked against that growth before investing.

What is the market cap of Laurus Labs, SBI Funds Management and Aditya Birla Capital?

Ans. As of 16 October 2026, Laurus Labs has a market cap of Rs 1,09,143 crore, SBI Funds Management has a market cap of Rs 1,05,732 crore and Aditya Birla Capital has a market cap of Rs 1,04,535 crore. All of them qualify as largecaps. Market cap changes daily with the share price, so check the latest figure on the Univest Screener or on NSE before taking a decision on FII and DII both buying stocks.

What are the risks of investing in FII and DII both buying stocks?

Ans. The main risks are changes in fund flows, valuations that already reflect strong interest and market swings. Companies with steady earnings and varied investors handle these better. Laurus Labs trades at a PE of 100.10 against an industry PE of 36.42, so earnings growth needs to hold up.

Why is Laurus Labs trading at a PE of 100.10?

Ans. Laurus Labs' PE of 100.10 compares with an industry PE of 36.42. The market is paying a premium for a return on equity of 16.77%, latest-quarter profit growth of 124.73% and FY26 revenue growth of 22.01%, which also means the stock is more sensitive if growth slows. Investors in FII and DII both buying stocks who are comfortable with higher valuation risk may prefer to stagger purchases instead of investing in one go.

How much do institutions hold in Laurus Labs, SBI Funds Management and Aditya Birla Capital?

Ans. As of the latest reported quarter, FII and DII together hold 41.74% of Laurus Labs (28.00% and 13.74%), 4.40% of SBI Funds Management (1.43% and 2.97%) and 22.08% of Aditya Birla Capital (8.60% and 13.48%). Rising institutional holding is a useful signal in FII and DII both buying stocks, though it should be read with earnings trends rather than on its own.